Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
On November 12, 2026, Health
In Tech, Inc., a Nevada corporation (the “Company”), prepared an investor presentation that officers and other representatives
of the Company intend to present at conferences and meetings. A copy of the investor presentation is furnished as Exhibit 99.1 of this
Current Report on Form 8-K. The information set forth in this Item 7.01 of this Current Report on Form 8-K and in the attached Exhibit
99.1 is deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information
set forth in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed incorporated by reference into
any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such
filing.
Certain statements in this
Current Report on Form 8-K or in the accompanying exhibits are forward-looking statements for purposes of the safe harbor provisions under
the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health
In Tech’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive
position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms
such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,”
“expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,”
“believe,” “continue,” “predict,” “project,” “potential,” “goal,”
“objective” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events
or to Health In Tech’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may
cause Health In Tech’s actual results, levels of activity, performance, or achievements to be different from any future results,
levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance
on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases,
beyond Health In Tech’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements.
Some of the risks and uncertainties, although not all risks and uncertainties, that could cause the Company’s actual results to
differ materially from those presented in its forward-looking statements are set forth in the “Risk Factors” section in the
Company’s Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities
and Exchange Commission, as such risks, uncertainties and other important factors may be updated from time to time in the Company’s
subsequent reports. Any forward-looking statement reflects Health In Tech’s current views with respect to future events and is subject
to these and other risks, uncertainties and assumptions relating to Health In Tech’s operations, results of operations, growth strategy
and liquidity. Health In Tech undertakes no obligation to update any forward-looking statements, except as required by law.
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Exhibit
99.1

An AI-Powered Marketplace Platform Helping Small- and Medium-Sized Businesses Access Better Self-Funded Health Plans

Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT," "we," "our," or "us") solely for informational purposes. The information included herein in this presentation has not been independently verified. No representations, warranties or undertakings, express or implied, are made by the Company or any of its affiliates, advisers or representatives as to, and no reliance should be placed upon, the accuracy, fairness, completeness or correctness of the information or opinions presented or contained in this presentation. By viewing or accessing the information contained in this presentation, you acknowledge and agree that to the fullest extent permitted by law, none of the Company or any of its affiliates, advisers or representatives accept any responsibility whatsoever (in negligence or otherwise) for any loss howsoever arising from any information presented or contained in this presentation or otherwise arising in connection with the presentation. Any industry and market data used in this presentation have been obtained from third-party industry publications and sources as well as from research reports prepared for other purposes. The Company has not independently verified the data obtained from the sources and cannot assure you of the data's accuracy or completeness. The information presented or contained in this presentation is subject to change without notice and its accuracy is not guaranteed. None of the Company or any of its affiliates, advisers or representatives make any undertaking to update any such information subsequent to the date hereof. This presentation should not be construed as legal, tax, investment or other advice. This presentation does not constitute or form part of, and should not be construed as, an offer to sell or issue or the solicitation of an offer to buy or acquire securities of the Company, nor shall there be any sale of securities in any state or other jurisdiction to any person or entity to which it is unlawful to make such offer, solicitation or sale in such state or jurisdiction. No part of this presentation shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. Specifically, these materials do not constitute a "prospectus" within the meaning of the U.S. Securities Act of 1933, as amended, and the regulations enacted thereunder. This presentation does not contain all relevant information relating to the Company or its securities, particularly with respect to the risks and special considerations involved with an investment in the securities of the Company. In evaluating its business, the Company uses certain non-GAAP measures as supplemental measures to review and assess its operating and financial performance. These non-GAAP financial measures have limitations as analytical tools, and when assessing the Company's operating and financial performances, investors should not consider them in isolation, or as a substitute for any consolidated statement of operations data prepared in accordance with U.S. GAAP. Reconciliation of any non-GAAP financial measures to their closest corresponding GAAP measures is provided in the Appendix to this presentation. This presentation contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding possible or assumed operational results, financial condition and outlook, business strategies and plans, market trends and opportunities, competitive position, industry environment and potential growth opportunities of the Company. These forward-looking statements are based on current expectations, estimates, forecasts and projections. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "objectives", "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms and similar expressions that convey the uncertainty of future events or outcomes are intended to identify these forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control. Factors that could cause actual results to differ from those projected include, but are not limited to, the following: the Company's liquidity position and ability to access capital; The Company's ability to identify, negotiate, finance, complete and integrate acquisitions or other strategic transactions and investments on favorable terms, or at all; the Company's ability to regain and maintain compliance with the Nasdaq Stock Market LLC continued listing requirements; the Company's ability to continue as a going concern; employee attrition, the Company's ability to successfully integrate new management, and the Company's ability to retain senior management and other key personnel; the Company's ability to enhance its existing products and services; product and service quality issues; and market competition. Further information on these and other factors that could affect the Company's financial results is included in the reports on Form 10-K, Quarterly Reports on Form 10-Q and other periodic filings with the Securities and Exchange Commission from time to time. Because of the risks and uncertainties, the Company cautions you not to place undue reliance on these statements, which speak only as of the date of this presentation. There may be additional risks of which we are not presently aware or that we currently believe are immaterial which could have an adverse impact on our business. Except as expressly required by the federal securities laws, we undertake no obligation, and specifically disclaim any obligation, to release any revision to any forward-looking statements to reflect events or circumstances after the date of this presentation or to reflect the occurrence of unanticipated events. 2

Health In Tech – Innovating Healthcare Insurance Market (1) Sources: Centers for Medicare & Medicaid Services 2024 Data and IBISWorld Assessment: Health & Medical Insurance in the US - Market Size (2004-2032), available, respectively, at: https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/historical & https://www.ibisworld.com/united-states/market-size/health-medical-insurance/1324/ 3 An AI-enabled marketplace connecting brokers, third-party administrators (TPAs), managing general underwriters (MGUs), insurance carriers and service partners to simplify the design, underwriting, quoting and placement of customized self-funded health plans for employers. HOW OUR MARKETPLACE WORKS Employers / Brokers & TPAs Submit plan needs and specifications H I T M AR K E T P L A C E Plan design • Stop-loss Underwrite & quoting • Placement & service workflows Carriers / MGUs / Provider Partners Provide underwriting criteria, risk capacity HIT Helps Small & Medium Size Businesses ("SMBs") Access Cheaper Healthcare Faster through its Proprietary Product Suite Operates in Massive Under-Penetrated Market(1) Established, Scalable, Profitable, High Growth Business Fee-Driven Business with No Plan or Underwriting Risk Exposure Highly Aligned Executive Leadership with Significant Ownership

I Business Overview

A Diversified Product Portfolio on HIT's Marketplace (1) Program currently in development. 5 Four distinct offerings that leverage HIT's platform tools to serve employers, brokers, managing general underwriters ("MGUs"), carriers and ecosystem partners. Product Offering Description Key Value 1-Year Rate Product One-year self-funded health plan with stop-loss protection • Leverages SMR for customized plan design • Leverages eDIYBS for AI-enabled underwriting and quoting Tailored coverage with risk protection Flexible, cost-effective for employers A stop-loss marketing and placement workflow platform • End-to-end quotation, market routing and binding workflow • Used by brokers, MGUs and carriers Streamlined distribution and placement Broader market access through one platform 3-Year Rate Stabilization Program(1) A multi-year self-funded plan with rate stability • Leverages SMR for plan customization and multi-year design • Leverages eDIYBS for underwriting and risk assessment Three-year rate certainty with self-funded flexibility Greater cost predictability for employers HitChain(1) A blockchain-based claims administration and settlement platform • Designed to streamline claims processing and payment settlement • Connects healthcare providers, third-party administrators ("TPAs") and payers through secure, verifiable workflows Faster provider payment and greater transparency Shared, verifiable data across the claim lifecycle HIT Platform functionalities Plan design & customization Underwriting & risk assessment Provider network integration

1-Year Rate Product 6 A 12-month self-funded health plan bundled with stop-loss protection. (1) Our platform generates bindable quotes in about 2 minutes for employer groups of 10–100 employees and about two weeks for groups exceeding 100 employees; legacy quoting takes about 12 days for groups of 10–100 employees. (2) Intercept Health October 2024, "The Hidden Cost of Fully Insured Plans: Why Self-Funding is Usually Better for Employers - intercept.health," (3) As of September 30, 2026. ~2 min Bindable quote for groups of 10–100 employees, vs. ~12 days via legacy process (1) 15–20% Estimated savings of self- funding vs. fully insured plans(2) 12 Plan options across 4 coverage tiers 1.5M+ Provider locations across 50 states in the HI Performance Network(3) CUSTOMIZED SELF-FUNDED HEALTH PLAN Employer-funded medical claims with tailored benefits and administrative arrangements for the employer group + STOP-LOSS INSURANCE Carrier-provided protection against high-cost claims within the self-funded plan structure

Problem: Access to Self-Funded Healthcare Plans (1) KFF 2025 Employer Health Benefit Survey, "2025 Employer Health Benefits Survey - Summary of Findings." (2) Intercept Health October 2024, "The Hidden Cost of Fully Insured Plans: Why Self-Funding is Usually Better for Employers - intercept.health," 7 Businesses want the cost and flexibility benefits provided by Self-Funded Healthcare Plans ("SFPs") Health In Tech's AI-powered solutions help remove barriers, enabling SMBs to benefit from SFPs Self-funded plans provide material benefits vs. fully insured plans. Complexity of successfully implementing self- funded plans has impacted market penetration, especially for small businesses with limited resources. Complexity of SFPs have made implementation unrealistic for many business 15 – 20% Self-Funded Plan Penetration %(1) Small Business 27% Large Business 80% Estimated Self-Funded Savings(2)

8 P h a r m a c y B e n e fi t M a n a g e r s B ro k er s T P A s H ea lt hc ar e N et w or k s Te le m e d C o m p a ni e s M e di c al M G M T C o m p an ie s C ar ri er s Manages relationship with brokers, third-party administrators ("TPAs"), and other vendors to create uniquely tailored cost saving plans Pulls understanding of vendor needs and capabilities into a singular clear platform Helps solves the complexity issue for SMBs Plan Design & Customization: SMR

Underwriting & Risk Assessment: eDIYBS (1) About 12 days for employer groups of 10–100 employees & about 3 months for groups exceeding 100 employees (2) About 2 minutes for employer groups of 10–100 employees & about two weeks for groups exceeding 100 employees 9 Legacy Quoting Procedures Bindable Proposal Presented 4 Tiers 12 Plans ~2 minutes to 2 weeks(2) ~12 days to 3 months(1) Applications Package Creation Quotes Final Quote Nurse Review Bindable Proposal Speed and ease of bindable quotes allow for enhanced plan flexibility and cost savings eDIYBS is a proprietary software offering which allows brokers to access bindable self- funded plan quotes in minutes Workflow is trained via proprietary healthcare data vs. public data sets

Nationwide Coverage: HI Performance Network (1) As of September 30, 2026. (2) https://advancedbenefitconsulting.com/reference-based-pricing-key-to-solving-health-insurance-industry-cost-issues/ 50 States(1) 1.5M+ Provider Locations (1) 10 Nationwide reach with direct Medicare-based contracts across 50 states (1) Medicare-based pricing drives 20%+ average cost savings vs. traditional commercial rates (2) Seamless integration with HIT's platform enables real-time claims and care coordination

HitRix 11 THE PROBLEM THE HITRIX SOLUTION WHY HITRIX IS DIFFERENT Fragmented submissions Same case rekeyed across markets Slow follow-up Emails, spreadsheets and portals create delays Hard to compare Quotes arrive in different formats Ingest AI document intelligence Route One-click multi-carrier marketing Compare Configurable proposal comparison Bind Digital placement & binding Single coordinated workflow Centralized communication and live case tracking Decision-ready comparison of pricing, coverage terms and employer risk Built on HIT's existing marketplace and underwriting infrastructure One Submission Multiple Options More Informed Placement Decisions Broker-first marketplace brings submission intake, market routing, quote comparison and case tracking into one coordinated process.

3-Year Rate Stabilization Program 12 A self-funded health plan with rates locked for three years — giving employers multi-year budget certainty. One rate, locked for three years Employers secure a single stabilized rate for a full three-year term, replacing the annual re-pricing cycle. Self-funded flexibility, retained Keeps the advantages of a self-funded plan without the usual annual rate swings. Claim reserves held in trust Employer claim funds are held in a dedicated trust and invested over the term; then returned to the employer after three years. A differentiated market offering A multi-year rate lock is rare, giving brokers a distinctive product and extending HIT's platform advantage. Rate Path: Market vs. HIT Year 1 Year 2 Year 3 Market: annual increases HIT: flat, locked rate Typical 1-year market rate HIT 3-year locked rate

HitChain 13 Today: slow, fragmented claim payments Slow to pay Providers often wait 30–45 days for payment through manual, multi-step processing. Error-prone Eligibility, coding and repricing issues can trigger denials, disputes and rework. Opaque No shared source of truth across hospitals, TPAs and employers. Value across the ecosystem Hospitals & providers Faster settlement and lower accounts-receivable burden. Employers / plan sponsors Greater cost visibility and more real- time, secure plan data. TPAs, MGUs & carriers Cleaner workflow, fewer manual touches and more reliable shared claim data. HitChain An integrated platform from claim adjudication to payment settlement HIT TPA Claims Adjudication & Routing Verify eligibility & benefits Reprice claim Apply plan rules & edits Route to payment settlement HitChain Payment Settlement & Blockchain Record Process provider payment (e.g., Stripe) Record EOB / EOP(2) on blockchain Create an immutable, shared ledger 1 Claim intake 2 Adjudicate & reprice 3 Instant settlement 4 On-chain record Up to $300B(1) Estimated annual U.S. healthcare claims adjudication costs A blockchain-enabled platform designed to modernize healthcare claims administration, accelerate provider payments and improve transparency across the claim lifecycle. (1) Peter Orszag and Rahul Rekhi, "Real-Time Adjudication for Health Insurance Claims," 1% Steps for Health Care Reform, January 2021. (2) EOB = Explanation of Benefits; EOP = Explanation of Payment.

How HIT Makes Money Today (1) Refer to the Company's 10-Q filing for the period ended September 30, 2026. (2) Per Employee Per Month fee based on size of business. 14 1-Year Rate Product Self-funded health plan with stop-loss REVENUE STREAMS X% of premium(1) PEPM fee(2) for 12 months HitRix Stop-loss marketing and placement platform REVENUE STREAMS X% of premium PEPM platform fee 3-Year Rate Stabilization Program Multi-year self-funded plan with rate stability REVENUE STREAMS PEPM fee for 3 years X% of residual unused funds in trust HitChain Blockchain-based claims and payment infrastructure REVENUE STREAMS X% of cost savings Transaction service fee (per payment) Recurring, fee-based revenue across 12-month and 36-month programs Diversified revenue streams from premium, PEPM, cost savings and transaction fees Greater client value and retention through an integrated platform

HIT By The Numbers (1) Contracted Revenue includes contractual revenue associated with policies that are in force at any time during the applicable reporting period. If a policy expires or lapses during the reporting period, Contracted Revenue includes revenue attributable to that policy only through its expiration or lapse date, and no revenue is included for periods thereafter. (2) Pipeline Revenue represents revenue from self-funded plan policies that are being quoted, are in binding status, or have been contracted subsequent to the end of the reporting period. This metric reflects the entire contractual term of the underlying policies, some of which may not ultimately convert to revenue. Management estimates a closing rate of 3% to 7% for the remaining sales opportunities. (3) Platform Placed Plan Value represents the aggregate contractual value of self-funded health plans with stop-loss insurance (self-funded stop-loss plans) placed through the Company's platform during the fiscal year through the applicable fiscal quarter end, measured over each plan's full contractual term of typically 12 or 36 months from the plan's effective date. (4) Adjusted EBITDA represents our net income (loss) attributable to common stockholders before net interest expense, taxes and amortization expense, adjusted to eliminate stock-based compensation expense, including employer payroll taxes related to stock- based awards, provision for credit losses on other receivables and loans receivable, financing transaction costs, change in fair value of standby equity purchase agreement derivative liability, change in fair value of convertible notes and other non-recurring items. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP. Please refer to Appendix Slide 23 of this presentation for a reconciliation of Adjusted EBITDA to net income (loss) attributable to common stockholders, the most comparable GAAP measurement, for the three months and nine months ended September 30, 2025, and 2026. We exclude certain non-recurring or non-cash items when calculating Adjusted EBITDA. 15 As of September 30, 2026 35 States with Clients 357 Business Clients 984 Brokers, Agencies & TPAs $ $ $32.7M Contracted Revenue(1) $ $156.4M Pipeline Revenue(2) as of October 30, 2026 Revenue Adj. EBITDA(4) Q3 2026 $6.6M -22% YoY $(3.9)M n/a Q3 2025 $8.5M $1.0M FY 2025 $33.3M $4.1M Revenue Adj. EBITDA(4) 9M 2026 $23.4M -9% YoY $(6.6)M n/a 9M 2025 $25.8M $3.8M $ $ $ $91.8M Platform Placed Plan Value(3)

HIT is Powering and Accelerating AI Disruption 16 The Health In Tech marketplace wins — AI accelerates value inside our platform, not outside of it HIT is a marketplace platform uniting an ecosystem of vendors HIT is the platform disruptors use to access the marketplace and deliver growth Distribution and marketplace capabilities insulate HIT from single-vendor AI disruption

II Financials & Conclusion

Revenue and Forward Visibility (1) Contracted Revenue includes contractual revenue associated with policies that are in force at any time during the applicable reporting period. If a policy expires or lapses during the reporting period, Contracted Revenue includes revenue attributable to that policy only through its expiration or lapse date, and no revenue is included for periods thereafter. (2) Pipeline Revenue represents revenue from self-funded plan policies that are being quoted, are in binding status, or have been contracted subsequent to the end of the reporting period. This metric reflects the entire contractual term of the underlying policies, some of which may not ultimately convert to revenue. (3) Before the enrollment adjustment and refund liability. Total Revenue ($ in millions) Historical + 2026 Guidance $19.5 2024 $33.3 2025 ~$30.0 2026E +71% Contracted Revenue(1) ($ in millions) From 9M 2026 business activity, as of September 30, 2026 $32.7M $2.2M 2027 $6.1M Q4 2026 $24.4M(3) 9M 2026 (Recognized) Pipeline Revenue(2) ($ in millions) As of October 30, 2026 $156.4M $2.6M contracted post Q3 2026 $153.8M in quoting or binding 18

Distribution Partner Growth 19 Brokers, Third-Party Administrators (TPAs), and Agencies 692 778 849 858 896 933 984 3/31/25 6/30/25 9/30/25 12/31/25 3/31/26 6/30/26 9/30/26 +15.9% Year-over-Year Growth 9/30/25 → 9/30/26 +135 Net New Partners Added in trailing 12 months +42.2% Growth Since Q1 2025 692 → 984 distribution partners over six quarters

$5.8 $19.2 $19.5 $33.3 2022 2023 2024 2025 Conclusions Platform removes complexity and provides novel AI-powered products and solutions Operating in massive, underserved market based on legacy structures Established business model poised to drive outsized growth No plan risk or underwriting risk exposure Highly aligned leadership team 20 Revenue Revenue (in millions)

III Appendix

Financial Results (1) Please refer to Appendix Slide 23 of this presentation for a reconciliation of Adjusted EBITDA to Net (loss) income attributable to common stockholders, the most comparable GAAP measurement, for the quarters and nine months ended September 30, 2025, and 2026. 22 Three Months Ended 9/30 Nine Months Ended 9/30 (In millions) 2025 2026 2025 2026 Total Revenue $8.5 $6.6 $25.8 $23.4 Gross Profit $5.1 $3.1 $16.8 $11.5 Gross Margin Percent 60.6% 46.5% 65.1% 49.1% Provision for credit losses $0.0 $5.3 $0.0 $6.1 Total Operating Expenses $4.7 $11.5 $15.1 $25.5 Net Income (Loss) $0.5 $(7.1) $1.6 $(11.2) Income (Loss) before income taxes $0.6 $(9.3) $2.1 $(14.6) Adjusted EBITDA (1) $1.0 $(3.9) $3.8 $(6.6)

GAAP To Non-GAAP Reconciliation – Adjusted EBITDA(1) 23 Three Months Ended September 30, Nine Months Ended September 30, (in dollars) 2025 2026 2025 2026 Net income (loss) attributable to common stockholders 452,176 (7,066,413) 1,581,399 (11,165,718) Interest income (111,699) (44,627) (305,263) (181,666) Amortization expense 217,981 278,747 489,947 1,002,534 Income tax expense (benefit) 148,046 (2,147,653) 536,514 (3,437,610) Stock-based compensation expense, including employer payroll taxes related to stock-based awards 292,552 730,041 1,493,686 2,133,849 Provision for credit losses on other receivables - 2,582,529 - 3,322,302 Provision for credit losses on loans receivable - 863,992 - 863,992 Financing transaction costs - 799,630 - 799,630 Change in fair value of SEPA derivative liability - 2,235 - 2,235 Change in fair value of convertible notes – FVO - 69,502 - 69,502 Other non-recurring items - - - 37,341 Total net adjustments 546,880 3,134,396 2,214,884 4,612,109 Adjusted EBITDA 999,056 (3,932,017) 3,796,283 (6,553,609) (1) Adjusted EBITDA represents our net income (loss) attributable to common stockholders before net interest income, taxes and amortization expense, adjusted to eliminate stock-based compensation expense, including employer payroll taxes related to stock-based awards, provision for credit losses on other receivables and loans receivable, financing transaction costs, change in fair value of SEPA derivative liability, change in fair value of convertible notes and other non-recurring items. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP. We exclude certain non-recurring or non-cash items when calculating Adjusted EBITDA, and we believe this approach provides a more meaningful measure by offering a clearer view of our underlying operational performance.